statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire ROCKVILLE, Md., April 5, 2024...

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

I-Mab Announces Closing of the Divestiture of Business Operations in China I-Mab Announces Closing of the Divestiture of Business Operations in China PR Newswire ROCKVILLE, Md., April 2, 2024...

I-Mab Announces Closing of the Divestiture of Business Operations in China

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

I-Mab price target lowered by $5 at Piper Sandler, here's why

I-Mab price target lowered by $10 at H.C. Wainwright, here's why

I-Mab Reports Full Year 2023 Financial Results and Business Update I-Mab Reports Full Year 2023 Financial Results and Business Update PR Newswire ROCKVILLE, Md., March 14, 2024 Recently announced...

I-Mab Reports Full Year 2023 Financial Results and Business Update

I-Mab: Trading Below Net Cash With Multiple Upside Options...

I-Mab: Trading Below Net Cash With Multiple Upside Options

I-Mab Signs Agreement to Divest its Assets and Business Operations in China I-Mab Signs Agreement to Divest its Assets and Business Operations in China PR Newswire ROCKVILLE, Md., Feb. 7, 2024...

I-Mab Signs Agreement to Divest its Assets and Business Operations in China

Looking Into I-MAB's Recent Short Interest

I-Mab to divest Chinese assets amid rising geopolitical tensions...

I-Mab to divest Chinese assets amid rising geopolitical tensions

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China.

Volume	109,542.00
52-Wk High	$3.45
52-Wk Low	$1.16

IMAB I-Mab - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals